ResMed
726 hedge funds and large institutions have $19.7B invested in ResMed in 2022 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 234 increasing their positions, 241 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
726
Holders Change
+64
Holders Change %
+9.67%
% of All Funds
11.71%
Holding in Top 10
11
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-26.67%
% of All Funds
0.18%
New
115
Increased
234
Reduced
241
Closed
35
Calls
$50.6M
Puts
$30.6M
Net Calls
+$20M
Net Calls Change
-$13.6M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$47.6M |
| 3 |
N
Natixis
Paris,
France
|
+$44M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$43.2M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$38M |
Top Sellers
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$413M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$99.5M |
| 3 |
Millennium Management
New York
|
-$76.4M |
| 4 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
-$50.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$38.2M |
